PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New Pharmaceutical Sustainability Guide Tackles Growing Industry Pressures

Tunley Environmental has launched a new science-based guide to help pharmaceutical and medical device companies respond to growing sustainability, procurement and product environmental expectations.

Tunley Environmental has launched its new Guide to Sustainable Pharmaceuticals, providing pharmaceutical and medical device organisations with a practical roadmap for navigating carbon, compliance, product lifecycle assessment, supply chains and environmental risk.

Health and Law flat lay. Judge gavel, medicine and doctor coat on blue background, top view. Medical malpractice, personal injury attorney.

The pharmaceutical sector faces a particularly complicated sustainability challenge. Organisations must reduce environmental impacts while continuing to protect patient safety, product quality, efficacy, regulatory compliance and continuity of supply.

Expectations are increasing around NHS procurement, Carbon Reduction Plans, Scope 3 emissions, product environmental evidence and sustainability claims.

The new guide brings these issues together and explores key pressures currently reshaping pharmaceutical sustainability, including PPN 006, the NHS Net Zero Supplier Roadmap, NHS Evergreen, PAS 2090:2025, growing demand for supply-chain data, and increasing focus on water, pollution, antimicrobial resistance, climate and nature-related risks.

It also sets out six practical pillars for pharmaceutical sustainability:

  • Governance, compliance and patient-first change
  • Carbon, energy and climate resilience
  • Product lifecycle assessment and eco-design
  • Responsible supply chains, water and nature
  • Circularity, materials and waste
  • Evidence, reporting and credible communication

Dr William Beer, CEO of Tunley Environmental, said:

“Pharmaceutical organisations are experience immense environmental expectations from several directions at once. 

This guide gives organisations knowledge on bringing carbon, product evidence, procurement, compliance and supply-chain resilience together into a more coherent sustainability strategy.”

Tunley Environmental supports pharmaceutical organisations, medical device companies and healthcare suppliers across carbon accounting, Product Carbon Footprints, Life Cycle Assessments, Scope 3 engagement, water, nature, climate risk, environmental compliance and sustainability verification.

Download the Guide to Sustainable Pharmaceuticals here: https://www.tunley-environmental.com/a-guide-to-sustainable-pharmaceuticals

About Tunley Environmental – Leeds, UK-based Tunley Environmental is a science-based sustainability consultancy helping organisations understand, manage and reduce their environmental impacts. Its team of PhD-level scientists supports businesses across carbon, life cycle assessment, biodiversity, water and environmental compliance, translating complex data and evolving compliance requirements into tangible action. Working with organisations internationally, Tunley delivers tailored, evidence-based solutions that strengthen strategy, increase progress and create lasting environmental and commercial value.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026